Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-01 11:20 am Purchase | 13G | Barinthus Biotherapeutics plc. BRNS | M&G Plc | 5,197,349 13.190% | 5,197,349 (New Position) | View |
| 2024-10-15 11:07 am Purchase | 13G | Barinthus Biotherapeutics plc. BRNS | Cawood Frank Wayne | 2,342,770 5.900% | 2,342,770 (New Position) | View |
| 2024-02-13 10:17 am Unchanged | 13G | Barinthus Biotherapeutics plc. BRNS | M&G INVESTMENT MANAGEMENT LTD | 5,197,349 13.480% | 0 (Unchanged) | View |
| 2023-01-20 1:35 pm Unchanged | 13G | Barinthus Biotherapeutics plc. BRNS | M&G INVESTMENT MANAGEMENT LTD | 5,197,349 13.940% | 0 (Unchanged) | View |
| 2022-10-07 4:36 pm Purchase | 13G | Barinthus Biotherapeutics plc. BRNS | M&G INVESTMENT MANAGEMENT LTD | 5,197,349 13.970% | 5,197,349 (New Position) | View |
| 2022-02-11 10:00 am Purchase | 13G | Barinthus Biotherapeutics plc. BRNS | Oxford Science Enterprises plc | 8,797,770 25.220% | 8,797,770 (New Position) | View |
| 2022-01-19 08:27 am Unchanged | 13G | Barinthus Biotherapeutics plc. BRNS | M&G Alternatives Investment Management Ltd | 4,108,752 11.970% | 0 (Unchanged) | View |
| 2021-11-05 1:33 pm Purchase | 13G | Barinthus Biotherapeutics plc. BRNS | M&G Alternatives Investment Management Ltd | 4,108,752 11.970% | 4,108,752 (New Position) | View |